TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8776075

Group type: EXPERIMENTAL
Intervention: Chromium picolinate (400 micrograms per day)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 2254558

Group type: EXPERIMENTAL
Intervention: Low dose amiodarone, 200 mg/day (Group 2, n = 98)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Individually treated antiarrhythmic therapy (Group 1, n = 100)
Number of subjects: 312

Group type: COMPARATOR
Intervention: No antiarrhythmic therapy (Group 3 [control group], n = 114)
Number of subjects: 312
Study: 6994772

Group type: EXPERIMENTAL
Intervention: guanfacine 2 mg daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo preparation
Number of subjects: 20
Study: 31610073

Group type: EXPERIMENTAL
Intervention: REDCHiP (video-based telehealth intervention, 10 sessions)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Telehealth treatment (after all parents received it)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Telehealth treatment (for children who entered treatment above target)
Number of subjects: 42

Group type: COMPARATOR
Intervention: WAITLIST (usual care)
Number of subjects: 42
Study: 31811206

Group type: EXPERIMENTAL
Intervention: Cordimax stent
Number of subjects: 3697

Group type: COMPARATOR
Intervention: Xience V stent
Number of subjects: 3697
Study: 28531363

Group type: EXPERIMENTAL
Intervention: Nitrox28
Number of subjects: 108

Group type: COMPARATOR
Intervention: Air
Number of subjects: 108
Study: 27554184

Group type: EXPERIMENTAL
Intervention: Objective binge eating (OBE)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Subjective binge eating (SBE)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Eating-related psychopathology and depression symptoms
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Eating-related psychopathology, self-esteem, and anxiety
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 80
Study: 24498875

Group type: EXPERIMENTAL
Intervention: Normal weight group (BMI 18.5-24.9)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Overweight group (BMI 25.0-29.9)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Obese group (BMI ≥30.0)
Number of subjects: 30

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 30
Study: 22186099

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (non-EPA group)
Number of subjects: 0
Study: 20560108

Group type: EXPERIMENTAL
Intervention: Pioglitazone 30 mg once a day plus vildagliptin 50 mg twice a day
Number of subjects: 168

Group type: COMPARATOR
Intervention: Glimepiride 2 mg 3 times a day plus vildagliptin 50 mg twice a day
Number of subjects: 168
Study: 17113192

Group type: EXPERIMENTAL
Intervention: Sweetened vegetable taste during conditioning trials
Number of subjects: 21

Group type: COMPARATOR
Intervention: Unsweetened vegetable taste at test
Number of subjects: 21
Study: 15677780

Group type: EXPERIMENTAL
Intervention: Proactive call center support in addition to usual care
Number of subjects: 591

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 591
Study: 14753762

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training
Number of subjects: 2

Group type: COMPARATOR
Intervention: Conventional training
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Cavity margin angulation
Number of subjects: 2
Study: 10361530

Group type: EXPERIMENTAL
Intervention: Dietary advice to lower fat intake with decreased eating frequency
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dietary advice to lower fat intake with maintained eating frequency
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dietary advice to maintain fat intake with decreased eating frequency
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dietary advice to maintain fat intake with increased eating frequency
Number of subjects: 80
Study: 7676401

Group type: EXPERIMENTAL
Intervention: Hyperlipidemia (defined by serum total cholesterol and triglyceride levels)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Idiopathic DVT patients
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 59
Study: 1693055

Group type: EXPERIMENTAL
Intervention: 1-hour infusion of vancomycin (1.0 g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 2-hour infusion of vancomycin (1.0 g)
Number of subjects: 10
Study: 6112564

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Heparin and Atenolol combined
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study: 31430313

Group type: EXPERIMENTAL
Intervention: Brief intervention with personalized feedback on AUDIT results
Number of subjects: 560

Group type: COMPARATOR
Intervention: Health education leaflet (received by both groups)
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Brief intervention
Number of subjects: 560

Group type: COMPARATOR
Intervention: Both groups (intervention and control)
Number of subjects: 560
Study: 30386340

Group type: EXPERIMENTAL
Intervention: Autologous hematopoietic stem cell transplantation (AHSCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monthly cyclophosphamide
Number of subjects: 0
Study: 26459008

Group type: EXPERIMENTAL
Intervention: Distraction using a kaleidoscope during venipuncture
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group (no distraction) during venipuncture
Number of subjects: 144
Study: 24556154

Group type: EXPERIMENTAL
Intervention: Alcohol administration after 3-hour smoking deprivation
Number of subjects: 128

Group type: COMPARATOR
Intervention: Alcohol administration after overnight smoking deprivation
Number of subjects: 128
Study: 23158941

Group type: EXPERIMENTAL
Intervention: Qigong intervention (specific exercises developed by the Heidelberg School of Chinese Medicine)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Qigong intervention
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 8
Study: 19825948

Group type: EXPERIMENTAL
Intervention: Lapatinib 175 to 1,800 mg once daily
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Lapatinib 500 to 900 mg twice daily
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Lapatinib (any dosing)
Number of subjects: 81
Study: 17982547

Group type: COMPARATOR
Intervention: No preflaring of the cervical and middle root canal thirds (Group 1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cervical and middle root canal thirds enlarged with nickel‐titanium Orifice Opener instruments (Group 2)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cervical and middle root canal thirds enlarged with Gates‐Glidden drills (Group 3)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cervical and middle root canal thirds enlarged with LA Axxess burs (Group 4)
Number of subjects: 40
Study: 15744631

Group type: EXPERIMENTAL
Intervention: Hypericum extract (612 mg)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Sertraline (50 mg)
Number of subjects: 241
Study: 11782871

Group type: EXPERIMENTAL
Intervention: Troglitazone 400 mg/d
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Troglitazone 600 mg/d
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Troglitazone (both doses)
Number of subjects: 106
Study: 9840235

Group type: EXPERIMENTAL
Intervention: 20% LCT (Long Chain Triglycerides)
Number of subjects: 21

Group type: COMPARATOR
Intervention: 20% 1:1 mixture of LCT/MCT (Medium Chain Triglycerides)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Comparison between LCT and LCT/MCT
Number of subjects: 21
Study: 8307468

Group type: EXPERIMENTAL
Intervention: High carbohydrate meal (74% of energy)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High fat meal (71% of energy)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Comparison of high fat vs high carbohydrate meals
Number of subjects: 8
Study: 2648911

Group type: EXPERIMENTAL
Intervention: 4 months of daily chemotherapy with streptomycin, isoniazid, rifampin, and pyrazinamide
Number of subjects: 1710

Group type: EXPERIMENTAL
Intervention: 4 months of chemotherapy (3 times a week)
Number of subjects: 1710

Group type: EXPERIMENTAL
Intervention: 3 months of daily chemotherapy with streptomycin, isoniazid, rifampin, and pyrazinamide
Number of subjects: 1710
Study: 30097579

Group type: EXPERIMENTAL
Intervention: BCI-based attention intervention for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-intervention (ADHD-NI) group
Number of subjects: 0
Study: 27138236

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 38

Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 38
Study: 24279284

Group type: EXPERIMENTAL
Intervention: Structured diabetes education plus insulin therapy
Number of subjects: 1511

Group type: COMPARATOR
Intervention: Usual care plus insulin therapy
Number of subjects: 1511
Study: 22577038

Group type: EXPERIMENTAL
Intervention: Pregabalin 75 mg, administered 3 times daily for 3 days
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg, administered 3 times daily for 3 days
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo, administered 3 times daily for 3 days
Number of subjects: 150
Study: 20053952

Group type: EXPERIMENTAL
Intervention: Active rTMS (20 trains of 40 pulses at 20 Hz, intensity 90% of resting motor threshold)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 15
Study: 18176730

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural team-based, individually geared, low-intensity rehabilitation programme
Number of subjects: 194

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 194
Study: 16023771

Group type: EXPERIMENTAL
Intervention: DTwP vaccine injected in the buttock
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DTaP vaccine injected in the buttock
Number of subjects: 0

Group type: COMPARATOR
Intervention: DTwP vaccine injected in the thigh
Number of subjects: 0

Group type: COMPARATOR
Intervention: DTaP vaccine injected in the thigh
Number of subjects: 0
Study: 12601115

Group type: EXPERIMENTAL
Intervention: Phenylalanine loading test (Phe-L)
Number of subjects: 0
Study: 9920951

Group type: EXPERIMENTAL
Intervention: Structured cardiac-rehabilitation program (exercise group)
Number of subjects: 27
Study: 8872499

Group type: EXPERIMENTAL
Intervention: IVIG 200 mg/kg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: IVIG 400 mg/kg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: IVIG 600 mg/kg
Number of subjects: 21
Study: 8497014

Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (79 +/- 3% CHO)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Normal carbohydrate diet (47 +/- 8% CHO)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Low carbohydrate diet (12 +/- 1% CHO)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Trial 1 (baseline performance)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Trial 2 (after 24 h recovery)
Number of subjects: 18
Study: 3623782

Group type: EXPERIMENTAL
Intervention: Sucrose (23.8 g, 350 ml solution)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Caffeine (200 mg, 350 ml solution)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (350 ml solution)
Number of subjects: 7
Study: 30003794

Group type: EXPERIMENTAL
Intervention: Outreach letter and brochure recommending HPV vaccination followed by automated HPV vaccine reminders
Number of subjects: 1805

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1805
Study: 28705172

Group type: EXPERIMENTAL
Intervention: Rimonabant (20 mg od)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Orlistat (120 mg tds)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Metformin (500 mg tds)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Pioglitazone (45 mg od)
Number of subjects: 50
Study: 26410206

Group type: EXPERIMENTAL
Intervention: Mental visual imagery (MVI) programme (n = 17)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham verbal programme (control group, n = 10)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No intervention (stability group, n = 13)
Number of subjects: 40
Study: 24246434

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198
Study: 20937544

Group type: EXPERIMENTAL
Intervention: Individualised nutrition support
Number of subjects: 132
Study: 18826659

Group type: EXPERIMENTAL
Intervention: Available Fe intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Available Zn intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin B12 intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Riboflavin intake
Number of subjects: 0
Study: 16495704

Group type: EXPERIMENTAL
Intervention: BALI model (4-variable prognostic model including BUN >or=25 mg/dL, Age >or=65 years, LDH >or=300 IU/L, IL‐6 >or=300 pg/mL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ranson scoring system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glasgow scoring system
Number of subjects: 0

Group type: COMPARATOR
Intervention: APACHE II scoring system
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BALI model
Number of subjects: 0
Study: 15297138

Group type: COMPARATOR
Intervention: Standard conformal radiotherapy (CFRT) at 64 Gy
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: High dose conformal radiotherapy (CFRT) at 74 Gy
Number of subjects: 843
Study: 10757254

Group type: EXPERIMENTAL
Intervention: Methylphenidate (45 mg or 90 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg, 400 mg or 800 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 24
Study: 8663871

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 667

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 667
Study: 1758297

Group type: EXPERIMENTAL
Intervention: Walk/jog training (W/J)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Strength training (STREN)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (CONT)
Number of subjects: 57
Study: 6409208

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Amiloride
Number of subjects: 78

Group type: COMPARATOR
Intervention: Thiazides (long-term treatment)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Amiloride (substitution for thiazides in long-term treatment)
Number of subjects: 78
Study: 31006767

Group type: EXPERIMENTAL
Intervention: Alternate‐nostril yoga breathing (ANYB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Breath awareness (BAW)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Quiet sitting (QS)
Number of subjects: 50
Study: 28679772

Group type: EXPERIMENTAL
Intervention: Detection of ≥1 CTC/7.5 mL before NT
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Detection of ≥2 CTCs/7.5 mL before NT
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: CTC-negative patients with pathologic complete response (pCR)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Patients with CTCs and less tumor response
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Detection of ≥2 CTCs/7.5 mL before NT in HER2-positive and triple-negative patients
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: CTCs detected after NT
Number of subjects: 213
Study: 25835472

Group type: EXPERIMENTAL
Intervention: Panoply
Number of subjects: 166

Group type: COMPARATOR
Intervention: Expressive Writing
Number of subjects: 166
Study: 23402397

Group type: EXPERIMENTAL
Intervention: fotemustine and dacarbazine repeated on 3-week cycle
Number of subjects: 260

Group type: COMPARATOR
Intervention: dacarbazine alone repeated on 3-week cycle
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: fotemustine and dacarbazine plus IFN‐α2b three times per week
Number of subjects: 260

Group type: COMPARATOR
Intervention: dacarbazine plus IFN‐α2b three times per week
Number of subjects: 260
Study: 21511707

Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation (c-tDCS) of left M1 for 20 minutes
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sham tDCS of left M1
Number of subjects: 13
Study: 19675499

Group type: EXPERIMENTAL
Intervention: Creatine (Cr) supplementation (10 g Cr + 10 g dextrose)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (PL) (20 g dextrose)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (CON) (no treatment)
Number of subjects: 42
Study: 17115237

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser (1 W, 15 Hz, 60 s, two times)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Er:YAG laser (100 mJ, 3 Hz, 60 s, two times)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group without any treatment
Number of subjects: 9
Study: 15559351

Group type: EXPERIMENTAL
Intervention: Oxytocin infusion (2 ampules of oxytocin at 10 u/mL/amp added to 1000 mL saline at 40 mU/min)
Number of subjects: 88

Group type: COMPARATOR
Intervention: No oxytocin infusion (control group)
Number of subjects: 88
Study: 11698316

Group type: EXPERIMENTAL
Intervention: Local administration of meloxicam 7.5 mg
Number of subjects: 56

Group type: COMPARATOR
Intervention: i.v. administration of meloxicam 7.5 mg
Number of subjects: 56
Study: 9383806

Group type: EXPERIMENTAL
Intervention: GM-CSF (Leucomax, 5 micrograms/kg) administered subcutaneously for 10 days after chemotherapy
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (standard-dose chemotherapy without GM-CSF)
Number of subjects: 8
Study: 8031548

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (added if monotherapy was inadequate)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 309
Study: 2902274

Group type: EXPERIMENTAL
Intervention: Caesarean section combined with hepatitis B immunisation
Number of subjects: 447

Group type: COMPARATOR
Intervention: Vaginal delivery
Number of subjects: 447
Study: 4913962

Group type: EXPERIMENTAL
Intervention: Nifuratel (Magmilor)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Metronidazole (Flagyl)
Number of subjects: 96
Study: 30755265

Group type: EXPERIMENTAL
Intervention: Nicardipine (L-type calcium channel antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28199903

Group type: EXPERIMENTAL
Intervention: Rest intervals of 10, 20, and 40 seconds (randomized and counterbalanced)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Individuals with CAI
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Rest intervals of 10 to 40 seconds
Number of subjects: 48

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 48
Study: 26289810

Group type: EXPERIMENTAL
Intervention: High-intensity intermittent activities coupled with aerobic training (3 sessions of 60 minutes weekly for 8 weeks)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 24
Study: 24292212

Group type: EXPERIMENTAL
Intervention: ERG-positive tumors
Number of subjects: 1243

Group type: EXPERIMENTAL
Intervention: ERG-negative tumors
Number of subjects: 1243
Study: 20882400

Group type: EXPERIMENTAL
Intervention: Enhanced care plus the promotora contextual intervention
Number of subjects: 120

Group type: COMPARATOR
Intervention: Enhanced care alone
Number of subjects: 120
Study: 18165593

Group type: EXPERIMENTAL
Intervention: Nimesulide 90 mg orally twice daily
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 16445320

Group type: EXPERIMENTAL
Intervention: Clo-Sur P.A.D. hemostatic device
Number of subjects: 209

Group type: COMPARATOR
Intervention: Conventional manual compression
Number of subjects: 209
Study: 12492801

Group type: COMPARATOR
Intervention: Esmolol-induced controlled hypotension (CH) alone group (n=15)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Esmolol-induced controlled hypotension combined with acute normovolemic hemodilution (E-ANH group, n=15)
Number of subjects: 30
Study: 11776116

Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rocuronium
Number of subjects: 60
Study: 9298771

Group type: EXPERIMENTAL
Intervention: vVO2max (271 +/- 18 m x min(‐1))
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 92% of vVO2max
Number of subjects: 6

Group type: COMPARATOR
Intervention: Incremental treadmill test
Number of subjects: 6
Study: 8472517

Group type: EXPERIMENTAL
Intervention: ST-679 at 600 mg/die
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ST-679 at 1200 mg/die
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ST-679 at 1800 mg/die
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (600 mg/die)
Number of subjects: 60
Study: 3776982

Group type: EXPERIMENTAL
Intervention: Reading Center evaluations using photographic and visual field data
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Reading Center evaluations with additional information (medical history, refractive error, best corrected visual acuity)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Inter-observer agreement between Reading Center examiners
Number of subjects: 138
Study: 28714323

Group type: EXPERIMENTAL
Intervention: Individualized Wheelchair Skills Training Program (5 sessions of 30 minutes each)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 17
Study: 27401364

Group type: EXPERIMENTAL
Intervention: 400 mg EPA+DHA daily for 52 weeks
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: 800 mg EPA+DHA daily for 52 weeks
Number of subjects: 264

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264
Study: 24892462

Group type: EXPERIMENTAL
Intervention: High-fat meal (saturated fat)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: High-fat meal (polyunsaturated fat)
Number of subjects: 47

Group type: COMPARATOR
Intervention: HIV-infected (ART-naïve)
Number of subjects: 47

Group type: COMPARATOR
Intervention: HIV-infected (on ART)
Number of subjects: 47
Study: 22561774

Group type: EXPERIMENTAL
Intervention: Trimetazidine plus hydration with normal saline
Number of subjects: 400

Group type: COMPARATOR
Intervention: Hydration with normal saline only
Number of subjects: 400
Study: 20608252

Group type: EXPERIMENTAL
Intervention: Surrogate endpoint trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drugs approved based on surrogate endpoint trials
Number of subjects: 0